¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ : 2019-05-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ : 2019-05-10
±³À°ÀÏÀÚ : 2019-05-10
±³À°Àå¼Ò : °æÁÖ È­¹éÄÁº¥¼Ç¼¾ÅÍ  
±³À°ÁÖÁ¦ : ´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071  
À̸ÞÀÏ : diabetes@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : °æ»óºÏµµ
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 250,000¿ø      
ºñ°í »çÀüµî·Ï: Àü¹®ÀÇ-ȸ¿ø 130,000¿ø/ºñȸ¿ø 200,000¿ø »çÀüµî·Ï: Àü°øÀÇ ¹× ±âŸ-ȸ¿ø 70,000¿ø/ºñȸ¿ø 90,000¿ø ÇöÀåµî·Ï: Àü¹®ÀÇ-ȸ¿ø 200,000¿ø/ºñȸ¿ø 250,000¿ø ÇöÀåµî·Ï: Àü°øÀÇ ¹× ±âŸ-ȸ¿ø 90,000¿ø/ºñȸ¿ø 110,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 09:00~09:25 Overview: understanding the relationship between ¥â Cell dynamics and diabetes  °­½Å¾Ö(¿¬¼¼ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 09:25~09:50 GLP1 increases b cell regeneration by promoting a to b treansdifferentiation  ÀüÈñ¼÷(°¡ÃµÀÇ´ë ¾Ï´ç´¢¿¬±¸¿ø) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 09:50~10:15 Dynamic pathology of islet endocrine cells in diabetes  ¿ø±ÔÀå(¿µ³²ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 10:15~10:40 SREBP1c-PAX4 Axis in ¥â cell compensation  ±èÀç¹ü(¼­¿ï´ë »ý¸í°úÇкÎ) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1,2 11:30~12:10 Bring the spotlight onto a niche in diabetes research  ±èÀÎÁÖ(ºÎ»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room5 12:30~13:10 Managing diabetes in elderly: go easy and individualizes  ÀÌ¿ëÈ£(¿¬¼¼ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 14:10~14:35 Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease? - respect of cardiologist  Á¶Áø¸¸(°æÈñÀÇ´ë ½ÉÀå³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 14:35~15:00 Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease? - respect of endocrinologist  ¼­¼ºÈ¯(µ¿¾ÆÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 15:00~15:25 Does extreme risk category for CVD need for dyslipidemia management in Korean type 2 diabetic patients? - pro  ¹Úö¿µ(¼º±Õ°üÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 15:25~15:50 Does extreme risk category for CVD need for dyslipidemia management in Korean type 2 diabetic patients? - cons  ¹®¹Î°æ(¼­¿ïÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 16:10~16:35 Urinary EV miRNA in the prediction of DKD progression  ÀÌ´ëÈ£(°¡ÃµÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 16:35~17:00 RNA sequence tramscriptome in DKD  ¹Ú¹Ì¿µ(ºÎ»ê´ë ÀÇ»ý¸í¿¬±¸¿ø) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 17:00~17:25 Role of ACE2 in diabetic kidney disease  ¹èÀºÈñ(Àü³²ÀÇ´ë ½ÅÀå³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 17:25~17:50 Basic research in degenerative eye disease in diabetes  ¹ÚÅ°ü(¼øõÇâÀÇ´ë ¾È°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ : 2019-05-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »ï¼º¼­¿ïº´¿ø 2019 »ï¼º ¾È°ú ±Ý¿äÁý´ãȸ(¾È°úºÐ¾ßÀÇ ÀΰøÁö´É) : 2019-05-10
´ÙÀ½±Û ±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»ç Áý´ãȸ(°æºÎÀÓÆļ±¿°) : 2019-05-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
120 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø 2018³â È£½ºÇǽºÀÇ·á±â°ü Á¾»çÀÚ º¸¼ö±³À°°úÁ¤ : 2018-08-25 0 1,437 2018-07-28
119 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ±³À°ÀÚ ¼¼¹Ì³ª : 2018-08-25 0 666 2018-07-28
118 ¼­¿ï Çѱ¹À¯¹æ¾ÏÇÐȸ 2018 School of Breast Disease(Day 1) : 2018-08-25 0 578 2018-07-28
117 ´ëÀü ´ëÇѳëÀκ´ÇÐȸ ³ëÀÎȯÀÚÀÇ Ä¡·á¿Í º¯È­ÇÏ´Â ÀÇ·á : 2018-08-25 0 1,182 2018-07-28
116 ºÎ»ê 2018³â ´ëÇÑÁßȯÀÚÀÇÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ NIV ¿öÅ©¼¥ : 2018-08-25 0 892 2018-07-28
115 ÀÎõ 2018³â ´ëÇѺҾÈÀÇÇÐȸ Çϰ迬¼ö±³À° : 2018-08-25 0 619 2018-07-28
114 ¼­¿ï Çѱ¹¿©ÀÚÀÇ»çȸ ¿°Áõ¼º Àå Áúȯ Áø´Ü°ú Ä¡·á / ³»½Ã°æ ¹ßÀü ¿ª»ç : 2018-08-25 0 539 2018-07-28
113 ´ë±¸ ´ëÇѵÎÅëÇÐȸ ´ë±¸, °æºÏÁö¿ª º¸¼ö±³À°(¸¸¼ºÆíµÎÅë Áø´Ü ¹× Ä¡·á 6 ´Ü°è) : 2018-08-25 0 757 2018-07-28
112 °æ±â Á¦ 7ȸ ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¿ò : 2018-08-25 0 611 2018-07-28
111 ¼­¿ï Á¦2ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¼Ò¾Æ±â°èȯ±â ¿öÅ©¼ó ¿ÀÀü session(8.25) : 2018-08-25 0 998 2018-07-28
110 ¼­¿ï Á¦2ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¼Ò¾Æ±â°èȯ±â ¿öÅ©¼ó Interactive workshop(8.25) : 2018-08-25 0 700 2018-07-28
109 ±¤ÁÖ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Á¦99Â÷ Àü³²ºÏÁöȸ ¿¬¼ö°­Á : 2018-08-25 0 621 2018-07-28
108 ºÎ»ê ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ East Asian Conference of Neurointervention 2018 : 2018-08-25 0 255 2018-07-28
107 ¼­¿ï 2018³â Á¦11ȸ ¼­¿ï´ëÇб³º´¿ø ÀçÈ°ÀÇÇаú ¿¬¼ö°­Á : 2018-08-25 0 542 2018-07-28
106 ¼­¿ï 2018³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ(8/25) : 2018-08-25 0 267 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷